(Q39497260)

English

Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Hao-Tien Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hsin-I Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jih-Huong Guo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Shih-Hui Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Zhe-Kang Liao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Lih-Hwa Hwang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

0 references

publication date

30 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

130

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

2892-2902

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805477%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

The rationale and future potential of angiogenesis inhibitors in neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Suppression of lung tumor growth and metastasis in mice by adeno-associated virus-mediated expression of vasostatin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

LRP: a multifunctional scavenger and signaling receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Anti-angiogenesis: making the tumor vulnerable to the immune system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Combined GM-CSF and IL-12 gene therapy synergistically suppresses the growth of orthotopic liver tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

FOXP3 modifies the phenotypic and functional properties of regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

PD-L1 regulates the development, maintenance, and function of induced regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

VEGF as a mediator of tumor-associated immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26339

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39497260&oldid=1459395267"